Abstract
Lipopolysaccharide (LPS) was shown to prevent tumor growth in BALB/c mice when administered either prior to or after the inoculation of lethal doses of tumor cells. An attempt to elucidate the mechanism of this phenomenon utilizing in vivo protocols was made by the adoptive transfer of tumor protection with peritoneal cells as well as with cell-free peritoneal fluids obtained from non-tumor-bearing, LPS-stimulated syngeneic mice. The in vivo-activated peritoneal cells from LPS-treated mice were capable of adoptively transferring tumor protection at peritoneal cell to tumor cell ratios ranging from 1,000:1 to 100:1. Experiments were also performed that indicate that: (i) LPS exerts no direct toxic or inhibitory effect on the tumor cells, and (ii) that residual LPS present in cell and fluid preparations was not responsible for such protection.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander P., Evans R. Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol. 1971 Jul 21;232(29):76–78. doi: 10.1038/newbio232076a0. [DOI] [PubMed] [Google Scholar]
- Calderon J., Williams R. T., Unanue E. R. An inhibitor of cell proliferation released by cultures of macrophages. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4273–4277. doi: 10.1073/pnas.71.11.4273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Currie G. A., Basham C. Activated macrophages release a factor which lyses malignant cells but not normal cells. J Exp Med. 1975 Dec 1;142(6):1600–1605. doi: 10.1084/jem.142.6.1600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gery I., Waksman B. H. Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med. 1972 Jul 1;136(1):143–155. doi: 10.1084/jem.136.1.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grant C. K., Alexander P. Nonspecific cytotoxicity of spleen cells and the specific cytotoxic action of thymus-derived lymphocytes in vitro. Cell Immunol. 1974 Oct;14(1):46–51. doi: 10.1016/0008-8749(74)90168-3. [DOI] [PubMed] [Google Scholar]
- Grohsman J., Nowotny A. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid. J Immunol. 1972 Nov;109(5):1090–1095. [PubMed] [Google Scholar]
- HAUSCHKA T. S. Cell population studies on mouse ascites tumors. Trans N Y Acad Sci. 1953 Dec;16(2):64–73. doi: 10.1111/j.2164-0947.1953.tb01321.x. [DOI] [PubMed] [Google Scholar]
- Hibbs J. B., Jr Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. J Natl Cancer Inst. 1974 Nov;53(5):1487–1492. doi: 10.1093/jnci/53.5.1487. [DOI] [PubMed] [Google Scholar]
- Keller R., Hess M. W. Tumour growth and non-specific immunity in rats: the mechanisms involved in inhibition of tumour growth. Br J Exp Pathol. 1972 Oct;53(5):570–577. [PMC free article] [PubMed] [Google Scholar]
- Parr I., Wheeler E., Alexander P. Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA. Br J Cancer. 1973 May;27(5):370–389. doi: 10.1038/bjc.1973.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tripodi D., Hollenbeck L., Pollack W. The effect of endotoxin on the implantation of a mouse sarcoma. Int Arch Allergy Appl Immunol. 1970;37(6):575–585. doi: 10.1159/000230246. [DOI] [PubMed] [Google Scholar]
- Yang C., Nowotny A. Effect of endotoxin on tumor resistance in mice. Infect Immun. 1974 Jan;9(1):95–100. doi: 10.1128/iai.9.1.95-100.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yin E. T., Galanos C., Kinsky S., Bradshaw R. A., Wessler S., Lüderitz O., Sarmiento M. E. Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta. 1972 Jan 28;261(1):284–289. doi: 10.1016/0304-4165(72)90340-6. [DOI] [PubMed] [Google Scholar]